SPRX002

Overview

SPRX002 is an antigen receptor that binds to CD123 on cancer cells and may help other drugs better recognize cancer cells. 

SparkCures ID 594
Generic Name SPRX002
Treatment Targets

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.